News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Calais Philippe
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Calais Philippe (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 45,000 options to buy
@ $0.2834, valued at
$12.8k
|
|
| 05/10/2023 |
4
| Calais Philippe (Director) has filed a Form 4 on Transcode Therapeutics, Inc.|
Txns:
| Granted 9,500 options to buy
@ $0.2985, valued at
$2.8k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
3
| Calais Philippe (Director) has filed a Form 3 on Transcode Therapeutics, Inc. |
| 06/04/2019 |
4
| Calais Philippe (Director) has filed a Form 4 on CohBar, Inc.|
Txns:
| Granted 24,000 options to buy
@ $1.72, valued at
$41.3k
|
|
| 12/10/2018 |
4
| Calais Philippe (Interim Chief Executive Office) has filed a Form 4 on CohBar, Inc.|
Txns:
| Granted 96,000 options to buy
@ $3.57, valued at
$342.7k
|
|
| 06/07/2018 |
4
| Calais Philippe (Director) has filed a Form 4 on CohBar, Inc.|
Txns:
| Granted 200,000 options to buy
@ $8.86, valued at
$1.8M
|
|
| 06/07/2018 |
3
| Calais Philippe (Director) has filed a Form 3 on CohBar, Inc. |
| 05/04/2018 |
4
| Calais Philippe (Former Director) has filed a Form 4 on Marina Biotech, Inc.|
Txns:
| Granted 80,000 options to buy
@ $0.98, valued at
$78.4k
|
|
| 01/03/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|